LPM Home
Contact LPM





JRGS Home
Aims and Scope
Current Issue
Forthcoming Articles
Archive
Editors




Information For Authors
General Information
Preparation of Manuscripts
How to Submit
Publication Charges
Review Process
Copyright Information

Print Information for Authors
(PDF)


Licence for Users
(PDF)


For Referees


For Librarians

Download
Manuscript Submission Form
.doc, .rtf, .pdf

Publishing Information
Open Access Publishing
Our Publishing Model
Institutional Memberships

Start Your Own Journal

   

Library Publishing Media

  CALL FOR PAPERS
Med J Ad

F
orthcoming
CONFERENCE and EXHIBITION
RNAi2008
c
 
Journal of RNAi and Gene Silencing

 

Journal of RNAi and Gene Silencing (February 2006), 2(1), 154-160

New Methods and Technologies

Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles

Yusuke Ohnishi †‡, Katsushi Tokunaga ‡, Kiyotoshi Kaneko † and Hirohiko Hohjoh †*

ABSTRACT

Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically suppressing the expression of alleles associated with disease. To realize such allele-specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital, but is also difficult. Here, we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer’s disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type allelic sequences in their 3’-untranslated regions. We examined the effects of siRNA duplexes against the mutant alleles in allele-specific gene silencing and off-target silencing against the wild-type allele under heterozygous conditions, which were generated by cotransfecting the reporter alleles and siRNA duplexes into cultured human cells. Consistently, the siRNA duplexes determined to confer ASP-RNAi also inhibited the expression of the bona fide mutant APP and the production of either amyloid b 40- or 42-peptide in Cos-7 cells expressing both the full-length Swedish- and wild-type APP alleles. The present data suggest that the system with reporter alleles may permit the preclinical assessment of siRNA duplexes conferring ASP-RNAi, and thus contribute to the design and selection of the most suitable of such siRNA duplexes.

KEYWORDS: RNAi, allele-specific gene silencing, amyloid precursor protein, Swedish mutation, London mutation, reporter allele

† National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.

‡ Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

*Correspondence to: Hirohiko Hohjoh, Email: hohjohh@ncnp.go.jp, Tel: +81 42 342 2711, ext. 5951 , Fax: +81 42 346 1755

© Copyright Yusuke Ohnishi et al

(Received 06 February 2006; Accepted 13 February 2006)

 

Privacy | Disclaimer

©Library Publishing Media. All rights reserved.